Penumbra (PEN) Income from Continuing Operations (2014 - 2026)

Penumbra (PEN) reported Income from Continuing Operations of 32588000.0 for Q1 2026, down 16.99% year-over-year from 39258000.0 in Q1 2025, and down 31.09% quarter-over-quarter from 47294000.0 in Q4 2025.

Penumbra (PEN) Income from Continuing Operations (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Income from Continuing Operations data on file, last reported at 32588000.0 in Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 32588000.0, down 16.99% year-over-year; the trailing twelve-month figure through Mar 2026 was 170977000.0 (up 304.73% YoY), and the FY2025 annual result was 177687000.0, up 1168.11% from the prior year.
  • Income from Continuing Operations declined to 32588000.0 in Q1 2026 per PEN's latest filing, from 47294000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 54218000.0 in Q4 2023 and troughed at 60174000.0 in Q2 2024.
  • A 5-year average of 18422352.94 and a median of 18960000.0 in 2023 frame the typical range for Income from Continuing Operations.
  • The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations jumped 10725.32% in 2023, then plunged 417.37% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 3877000.0 in 2022, then surged by 1298.45% to 54218000.0 in 2023, then tumbled by 37.87% to 33683000.0 in 2024, then soared by 40.41% to 47294000.0 in 2025, then slumped by 31.09% to 32588000.0 in 2026.
  • Business Quant data shows PEN's Income from Continuing Operations at 32588000.0 in Q1 2026, 47294000.0 in Q4 2025, and 45825000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Penumbra 12.45 Bn 11.84 Bn 253.41 Mn 32.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.59 Mn
Dec 31, 2025 47.29 Mn
Sep 30, 2025 45.83 Mn
Jun 30, 2025 45.27 Mn
Mar 31, 2025 39.26 Mn
Dec 31, 2024 33.68 Mn
Sep 30, 2024 29.48 Mn
Jun 30, 2024 -60.17 Mn
Mar 31, 2024 11.03 Mn
Dec 31, 2023 54.22 Mn
Sep 30, 2023 9.20 Mn
Jun 30, 2023 18.96 Mn
Mar 31, 2023 8.55 Mn
Dec 31, 2022 3.88 Mn
Sep 30, 2022 -2.27 Mn
Jun 30, 2022 -3.69 Mn
Mar 31, 2022 79,000.00
Dec 31, 2021 -24.63 Mn
Sep 30, 2021 8.03 Mn
Jun 30, 2021 8.30 Mn